Agenus
AGEN
NZ$8.10
Share price
-6.18%
Change (1 day)
-68.10%
Change (1 year)
Categories
Agenus (AGEN) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$0.15 Billion
According to Agenus 's latest financial reports the company's total debt is NZ$0.15 Billion. A company’s total debt is the sum of all current and non-current debts.
Agenus - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$0.16 B | 20.25% |
| 2023-12-31 | NZ$0.13 B | 13.25% |
| 2022-12-31 | NZ$0.12 B | 44.76% |
| 2021-12-31 | NZ$85.33 M | 10.49% |
| 2020-12-31 | NZ$77.23 M | 122.35% |
| 2019-12-31 | NZ$34.73 M | 74.42% |
| 2018-12-31 | NZ$19.91 M | -91.32% |
| 2017-12-31 | NZ$0.22 B | 21.67% |
| 2016-12-31 | NZ$0.18 B | 12.8% |
| 2015-12-31 | NZ$0.16 B | 2074.51% |
| 2014-12-31 | NZ$7.69 M | -28.71% |
| 2013-12-31 | NZ$10.78 M | 3621.24% |
| 2012-12-31 | NZ$0.28 M | -99.31% |
| 2011-12-31 | NZ$42.18 M | -4.83% |
| 2010-12-31 | NZ$44.32 M | -35.14% |
| 2009-12-31 | NZ$68.34 M | -38.29% |
| 2008-12-31 | NZ$0.11 B | 9.4% |
| 2007-12-31 | NZ$0.10 B | -5.51% |
| 2006-12-31 | NZ$0.10 B | 1656.21% |
| 2005-12-31 | NZ$6.1 M | -56.13% |
| 2004-12-31 | NZ$13.9 M | -43.03% |
| 2003-12-31 | NZ$24.4 M | 2218.99% |
| 2002-12-31 | NZ$1.05 M | -92.83% |
| 2001-12-31 | NZ$14.68 M | 30.69% |
| 2000-12-31 | NZ$11.23 M | 95.68% |
| 1999-12-31 | NZ$5.74 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Merck MRK | NZ$58.08 B | 37,756.22% | 🇺🇸 USA |
 GlaxoSmithKline GSK | NZ$39.70 B | 25,774.65% | 🇬🇧 UK |
 Johnson & Johnson JNJ | NZ$87.10 B | 56,669.12% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | NZ$5.71 M | -96.28% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$85.42 B | 55,568.55% | 🇺🇸 USA |